Sun Pharmaceutical Industries Ltd. closed 14.47% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Sun Pharmaceutical Industries Ltd. closed 14.40% short of its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

India's Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of hair loss.

Sun Pharma has agreed a takeover deal with US biotech Checkpoint Therapeutics, which recently claimed FDA approval for its first drug but is also running low on cash. The Indian pharma group ...

What's driving this $370 million transformation? The global residual DNA testing market, valued at US$0.27 billion in 2024, ...

Data recorded during a heat wave earlier this month showed carriages on the central line — one of the oldest and deepest in the network at 20 meters (65.617 feet) below surface level — were ...

LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...

The Health Ministry has planned to provide 2000 direct jobs and 5000 indirect jobs by creating the "Suwasiripura Pharmaceutical Manufacturing Zone" at Oyamaduwa, Anuradhapura. The project is being ...

Mr. Bandara, who was the Chief Operating Officer of Sunshine Pharmaceuticals, counts more than 23 years of experience in the pharmaceutical industry. He joined Sunshine Healthcare in 2011 and rose ...